Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Impact Biomedical Inc. (IBO) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.00M |
|
$-0.70M |
|
$0.00M |
|
$0.00M |
|
$0.70M |
|
$-0.70M |
|
$0.00M |
|
$-0.70M |
|
$-0.70M |
|
$-0.70M |
|
$-0.70M |
|
$-0.70M |
|
$-0.70M |
|
$-0.70M |
|
$-0.42M |
|
107.82M |
|
107.82M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$0.32M |
|
-- |
|
$16.43M |
|
$16.75M |
|
$2.04M |
|
-- |
|
$0.69M |
|
$2.73M |
|
$14.01M |
|
$-2.41M |
|
$14.01M |
|
107.82M |
|
| Cash Flow Statement Financials | |
$0.01M |
|
$0.00M |
|
-- |
|
$0.00M |
|
$0.01M |
|
$0.01M |
|
$1.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.16 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
66.67% |
|
-23400.00% |
|
-23400.00% |
|
-- |
|
-23333.33% |
|
-23300.00% |
|
$0.01M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.02 |
|
-- |
|
-- |
|
-5.00% |
|
29.01% |
|
-4.18% |
|
-5.00% |
|
$0.13 |
|
$0.00 |
|
$0.00 |
|